CSIMarket
 


Immune Therapeutics Inc  (IMUN)
Other Ticker:  
 

Immune Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information


IMUN Profitability Ratio

Company Industry Sector S&P 500
Gross Margin (Q3 MRQ) - 69.98 % 48.52 % 45.68 %
Gross Margin (Q3 TTM) - 70.26 % 49.61 % 45.26 %
Gross Margin 5 Yr. Avg. - 67.62 % 50.35 % 47.7 %
EBITDA Margin (Q3 MRQ) - 26.23 % 12.14 % 17.59 %
EBITDA Margin (Q3 TTM) - 23.86 % 12.62 % 18.43 %
EBITDA Margin 5 Yr. Avg. - 21.13 % 15.18 % 37.82 %
Operating Margin (Q3 MRQ) - 15.3 % 8.42 % 14.72 %
Operating Margin (Q3 TTM) - 15.28 % 10.04 % 15.5 %
Operating Margin 5 Yr. Avg. - 12.91 % 10.69 % 14.63 %
Pre-Tax Margin (Q3 MRQ) - 13.65 % 5.42 % 10.51 %
Pre-Tax Margin (Q3 TTM) - 11.64 % 5.9 % 11.42 %
Pre-Tax Margin 5 Yr. Avg.